Johns Hopkins University
I am an Assistant Professor in the Department of Otolaryngology, Division of Head and Neck Cancer Research, Johns Hopkins School of Medicine. I have spent the past 12 years investigating molecular approaches for early detection and treatment of cancer. My research focus is on understanding the complex interplay between the genetic and epigenetic alterations in carcinogenesis and disease progression, and on exploiting this understanding for developing novel biomarkers for diagnosis and risk stratification as well as in identifying targets for therapeutic intervention. I am actively engaged in partnering with researchers and oncologists in academia and pharmaceutical industry worldwide, to advance discovery of biomarkers for early cancer detection and risk assessment and personalized therapy. I have received my Bachelor of Laboratory Medicine (B.Med.Lab.) and Master degree in Clinical Biochemistry (M.Med.Sc.) from Ben-Gurion University (BGU) School of Medicine, Israel, where I have graduated summa cum laude from the Faculty of Health Sciences. I received my Ph.D. from Ben-Gurion University via the BGU /Fox Chase Cancer Center Partnership Graduate Research Program. I have completed my first postdoctoral training at the University of Florida, and have joined Johns Hopkins University in 2012, where I have carried out seminal work in defining the clonal evolution and heterogeneity of solid tumor malignancies, at both the genetic and epigenetic levels. Based on my record of research accomplishments, I was invited to join the Department of Otolaryngology as an Instructor in 2016, and subsequently was promoted to the rank of Assistant Professor in May 2017. Using novel bioinformatic methods for extracting biologically-relevant features from large-scale genomic, my current work focuses on identification of molecular signatures that could efficiently predict patients’ response to anticancer treatment.